Generic filters
Exact matches only
Search in title
Search in content
Search in excerpt
View corresponding page on italian website CURASEPT.IT
Risk factors

RISK FACTORS AND ORAL HYGIENE

In case of theย presence of comorbidities or risk factorsย daily oral hygiene should be a step ahead. That is why we have developed the Prevent line:ย products for daily use for patientsย who haveย risk conditionsย such as smoking, obesity, diabetes, advancing age, dry mouth, poor immune system, which can facilitate the onset of inflammation such as mucositis and gingivitis, especially in people who have already suffered from gum problems. The line also represents theย idealย support forย prevention protocolsย for mucositis and peri-implantitis, thereforeย in the presence of dental implants, but also for the prevention ofย recurrencesย in patients already treated for periodontitis with natural teeth.

Thanks to theย innovative formulationย based on ozonated extra virgin olive oil and specific probiotics, theย Prevent system rebalances the oral microbiota every dayย counteracting the formation of plaque.

The advantage of the treatment is thatย it maintains the oral microbiota in a state of equilibrium (eubiosis),ย as an uncontrolled proliferation of the oral bacterial flora can facilitate anย excessive production of pathogenicย bacteria,ย such as obligate anaerobe Gram-negative bacteria, which are often responsible for implant and periodontal diseases.

It is also important to remember that certain health conditions, medications, and therapies can lead to xerostomia (dry mouth), which can have significant consequences on oral health. In addition to taste alterations and halitosis, dry mouth can, over time, cause mucosal lesions, an increase in cavities and gingivitis, and even periodontitis and oral candidiasis.

 

Show more
Select a category...
CURASEPT ADS | DNA HYALU PRO GEL
CURASEPT ADS | DNA PERIO PRO ORAL RINSE
CURASEPT ADS | DNA PERIO PRO TOOTHPASTE
gel Curasept Prevent and pack
CURASEPT PREVENT GEL
mouthwash and pack Curasept Prevent
CURASEPT PREVENT MOUTHWASH
CURASEPT PREVENT PROBIOTIC FOOD SUPPLEMENT
toothpaste and pack Curasept Prevent
CURASEPT PREVENT TOOTHPASTE

THE FIRST NON-STAINING CHLORHEXIDINE

The first Curasept mouthwashes and toothpastes with Chlorhexidine featuring A.D.S.ยฎย –ย Anti Discoloration System, an innovative, patented, and clinically tested system that reduces the appearance of yellow-brown spots on the teeth, which is the main side effect of Chlorhexidine.

A.D.S.ยฎย inhibits the two chemical reactions leading to pigmentation, without affecting the antiplaque activity of Chlorhexidine.ย 

Curasept ADS

small_c_popup.png

Vuoi accedere ai contenuti Extra? Registrati o fai Login per accedere ai contenuti a te dedicati: articoli, video ,schedeโ€ฆ e tanto altro!

Non sei registrato?
Clicca il pulsante qui sotto. La registrazione รจ gratuita.

Quality Policy

The Quality for CURASEPT S.p.A. is an essential condition to put itself successfully on the market, considering its characteristics and evolution.

The development of the Company and its profit are insured by the continuous search for quality towards excellence through the continuous improvement of its processes and the search for partners with quality systems adapted to our standards.

The Company aims to increase the customer satisfaction through the application of its Quality Management System, including the processes to improve the system and to ensure the compliance with the customer and applicable regulatory requirements.

For this purpose, the Company performs specific risks and opportunities assessment activities, connected to the context, stakeholders and related objectives, in order to identify the areas of system improvements and to define the appropriate actions for the risk control and mitigation and strengthening of its Quality System.

The starting point for the implementation of this policy is the pursuit of the following objectives:

  • Define and implement a Quality Management System according to 9001:2015+A1:2024 e UNI CEI EN ISO 13485:2021 regulation, as Manufacturer of Medical Devices;
  • Define and implement a system of procedures and operating instructions in harmony with the Directive 93/42/CEE, the Regulation (UE) 2017/745 and the Regulation (UE) 2023/607 for the applicable parts and subsequent changes and integrations, which satisfy the essential requirements set out in Annex I;
  • Define and implement a system of procedures in harmony with the Directive 2010/84, the Regulation 1235/2010, the Implementation Regulation n. 520/2012 and in accordance with the objectives of โ€œmodule I – โ€œGood Vigilance Practicesโ€ (GVP);
  • Establish and formalize the business organizational structure with the subdivision into areas of competences;
  • Clarify roles and responsibilities of business functions;
  • Define strategies and objectives and assign human and material resources for their achievement;
  • Define accurately business processes and related performance factors;
  • Ensure compliance with qualitative, quantitative and temporal requirements;
  • Constantly monitor the level of adequacy of the system with reference to regulations and laws;
  • Promote initiatives in order to improve the process of motivational and professional growth of human resources, considered as critical resources for future business developments;
  • Ensure the commitment to the satisfaction of requirements and the maintenance of effectiveness of the Quality Management System.

These objectives can be realized thanks to the involvement of the whole Company personnel.

In particular, the Managers of each Function provide their contribution so that the suggested improvements can be proposed to the General Direction, so that the Quality Policy can be a priority element in the choice of business qualitative and organizational strategies.

The involvement of the whole personnel in the improvement of internal and external processes should be aimed at reducing non-compliance and internal and external costs of non-quality; for this reason all employees should feel themselves committed in pursuing this policy.

Training courses, for all business levels, are promoted and planned by the General Direction in order to keep the personnel constantly up to date on the improvements performed for the processes.

The Quality Manual, which is distributed via the SistemaQualitร  to all process managers and the General Director, should represent a work tool for all Managers and their personnel for the implementation of the Quality Policy.

April 2025

General Direction